BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of James R. Meyers, an accomplished biopharmaceutical executive with over three decades of commercial leadership experience to Vera Therapeutics’ Board of Directors. "We are thrilled to welcome Jim to our Board of Directors at ...

Topic:Â Wednesday, 26 November 2025 04:05 PM Contact Us Back to the Newsroom Dubai's Gold Market Reset Is Underway, and SMX Is the Technology Driving It Company Update NEW YORK, NY / ACCESS Newswire / November 26, 2025 / Gold markets rarely change through sudden shocks. They change when a single region builds a structure so strong, so organized, and so future-ready that the rest of the world eventually has to follow. That is exactly what is happening in Dubai right now. The DMCC spent more than twenty years ...

Adjournment of Special Meeting The adjourned Special Meeting will be held in a virtual format and shareholders of record on October 17, 2025, will be able to listen and participate in the reconvened meeting, as well as vote and submit questions during the meeting by dialing 1-888-788-0099. The conference ID number for the Special Meeting is 85737219104. PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW) ("Pixelworks" or the "Company"), a leading provider of innovative video and di ...

DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors (the “Board”) has unanimously approved an amendment to the Company’s existing shareholder rights plan (the “Rights Plan”), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms ...

NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on November 24, 2025, the Compensation Committee of the Orchestra BioMed Board of Directors granted stock options to purchase an aggregate of 151,250 shares of the Company’s common stock to 12 newly hi ...

NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Flutter Entertainment plc (“Flutter”) (NYSE: FLUT; LSE: FLTR), the world's leading online sports betting and iGaming operator, notes changes to gaming taxation announced by the UK Government in its autumn budget. The changes to UK online gaming taxation include: Effective from April 2026, iGaming increases 19 percentage points to 40 percentEffective from April 2027, Sports betting (ex-horseracing) increases 10 percentage points to 25 percent The adjusted EBITDA1 i ...

OXNARD, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”) a world leader in sourcing, producing, and distributing fresh Hass avocados, today announced the appointment of Douglas M. Stone to its Board of Directors, effective November 26, 2025. Stone is appointed as an independent Class I director with a term expiring at the Company’s 2027 Annual Meeting of Stockholders. In connection with this appointment, Mission Produce’s Board of Directors has incre ...

ATHENS, Greece, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: DLNG), an owner of liquefied natural gas carriers, conducted its Annual Meeting of Limited Partners on November 26, 2025, in Athens, Greece. The following resolutions were approved: To re-elect Alexios Rodopoulos as a Class II Director to serve for a three-year term until the 2028 Annual Meeting of Limited Partners; andTo ratify the appointment of Ernst & Young (Hellas) Certified Auditors Accountants S.A. as ...

MINNEAPOLIS, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that an abstract was accepted for an oral presentation at the 2025 San Antonio Breast Cancer Symposium (SABCS) and is now available on the SABCS website. The 2025 SABCS is being held virtually and in-person from December 9-12, 2025. The presentation will include additional sub-group efficacy analyses and safety data. Abst ...

NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in fireside chats at two upcoming investor conferences: 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 9:35 a.m. ET in Miami, FL. ...